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Regulatory T cells (Tregs), which are characterized by expression of the transcription factor Foxp3, are a 
dynamic and heterogeneous population of cells that control immune responses and prevent autoimmunity. 
We recently identified a subset of Tregs in murine skin with properties typical of memory cells and defined this 
population as memory Tregs (mTregs). Due to the importance of these cells in regulating tissue inflammation 
in mice, we analyzed this cell population in humans and found that almost all Tregs in normal skin had an 
activated memory phenotype. Compared with mTregs in peripheral blood, cutaneous mTregs had unique cell 
surface marker expression and cytokine production. In normal human skin, mTregs preferentially localized 
to hair follicles and were more abundant in skin with high hair density. Sequence comparison of TCRs from 
conventional memory T helper cells and mTregs isolated from skin revealed little homology between the two 
cell populations, suggesting that they recognize different antigens. Under steady-state conditions, mTregs 
were nonmigratory and relatively unresponsive; however, in inflamed skin from psoriasis patients, mTregs 
expanded, were highly proliferative, and produced low levels of IL-17. Taken together, these results identify 
a subset of Tregs that stably resides in human skin and suggest that these cells are qualitatively defective in 
inflammatory skin disease.
Introduction
Foxp3-expressing regulatory T cells (Tregs) play an indispensable 
role in establishing and maintaining immune homeostasis. It was 
originally thought that Tregs are a relatively homogenous popu-
lation generated exclusively in the thymus. However, subsequent 
studies revealed that an additional subset was derived from cells 
induced to become Tregs outside of the thymus (1), adding to the 
complexity of the ontogeny of this cell population. Emerging data 
suggest the existence of even more complexity, as multiple Treg 
subsets are being defined with specialized functions and unique 
cell fates. Perhaps the most distinct subsets of Tregs are those that 
reside in peripheral tissues. In the gastrointestinal tract, a popu-
lation of Tregs is induced by microbial flora and is specialized to 
secrete IL-10 (2). In visceral adipose tissue (VAT), a population of 
Tregs preferentially expresses the peroxisome proliferator–activated 
receptor γ (PPARγ), which confers highly specialized functions, 
including the expression of genes involved in lipid metabolism (3).
We recently characterized a distinct population of Tregs in 
murine skin (4, 5). Using an inducible model of cutaneous self-anti-
gen expression, we found that upon induction of antigen, thymus- 
derived Tregs are activated and accumulate in skin. A subset of 
these cells is maintained in the tissue for relatively long periods in 
the absence of antigen and has an enhanced capacity to suppress 
cutaneous autoimmunity when antigen is reexpressed. These cells 
fit stringent criteria for effector memory cells and were named 
memory Tregs or mTregs. Consistent with an effector memory 
phenotype, mTregs require IL-7 for their maintenance in skin (4).
Although studies characterizing specialized Treg subsets in 
murine tissues are beginning to emerge, very little is known about 
Tregs in human tissues. Given the limited accessibility of fresh 
human tissue, functional characterization of Tregs in humans has 
largely been limited to peripheral blood. Comprehensive analysis 
of Tregs in blood reveals a heterogeneous population composed 
of resting Tregs with a “naive” phenotype, “activated” Tregs with 
characteristics of memory cells, and Foxp3-expressing cells that 
secrete effector cytokines and lack suppressive capacity (6).
It is important to elucidate the fundamental biology of Tregs in 
human peripheral tissues in order to define abnormalities in these 
cells in inflammatory diseases and to exploit Tregs for treating 
such disorders. Tregs are thought to mediate the majority of their 
functions in the tissues in which they reside (7), and optimal ther-
apeutic approaches directed at either augmenting or inhibiting 
Tregs will most likely require strategies that target specific subsets, 
in an attempt to efficiently treat disease and limit systemic side 
effects. In this report, we phenotypically and functionally char-
acterize Tregs in human skin. Similar to the mTreg population 
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identified in mice, almost all Tregs in human skin have an effector 
memory phenotype. We show that mTregs in human skin have 
distinct cell surface marker expression, cytokine production, in 
situ localization, TCR expression, and functional capacity in both 
normal and diseased skin. These results reveal a unique subset of 
Tregs resident in human skin and suggest that these cells may be 
qualitatively defective in inflammatory skin disease.
Results
Tregs in normal human skin. A comprehensive analysis of immune 
cell populations in human skin has been hampered by technical 
challenges in obtaining adequate numbers of cells from relatively 
harsh digestion protocols. Consequently, the majority of studies 
published to date rely on either immunohistochemical analyses 
or assays in which skin cells are cultured for several days, some-
times in the presence of growth factors (8, 9). In order to objec-
tively study Tregs in human skin, we optimized a chemical diges-
tion method for isolating leukocytes from this tissue. Surgically 
discarded samples of clinically normal-appearing skin were gently 
digested overnight (in the absence of exogenous growth factors), 
and single-cell suspensions were immediately analyzed by 12-color 
flow cytometry. In order to control for potential artifacts in the 
isolation process, human PBMCs were processed in a manner 
identical to that used for skin. Adult human skin contains read-
ily detectable Foxp3-expressing CD4+ T cells (Figure 1A). Whereas 
approximately 5% of CD4+ T cells consistently express Foxp3 in 
adult peripheral blood, approximately 20% of CD4+ T cells in adult 
skin express Foxp3, with considerably more variability when com-
pared with that found in blood. Interestingly, greater than 95% of 
CD4+Foxp3+ cells in the skin express CD45RO, whereas 75%–80% 
of skin CD4+Foxp3– cells express this marker (Figure 1B). These 
results indicate that almost all of the CD4+Foxp3+ cells in adult 
skin have previously seen antigen (outside of the thymus), consis-
tent with a memory T cell phenotype. Interestingly, the percent-
age of CD4+Foxp3+ cells in human fetal skin is markedly reduced 
when compared with that in adult skin, with a significantly lower 
percentage of these cells expressing CD45RO (Figure 1C). As 
expected, CD45RO expression is also reduced on CD4+Foxp3– cells 
in fetal skin when compared with its expression in adult skin (Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI72932DS1). Taken together, these data 
support the notion that Tregs encounter skin-associated antigens 
over time and gradually accumulate in this tissue.
Tregs in human skin are activated memory cells. mTregs in murine 
skin express markers of prior activation as well as markers typ-
ical of effector memory T cells (4, 5). The fact that greater than 
95% of Tregs in normal human skin express CD45RO suggests 
that this population is a bona fide memory T cell population. To 
explore this further, we examined these cells for both activation 
and effector memory T cell markers (Figure 2A). Compared with 
CD45RO+CD4+Foxp3+ cells in adult peripheral blood (hereaf-
ter referred to as mTregs), the equivalent cell population in skin 
expressed significantly higher levels of the Treg activation markers 
CTLA-4 (extracellular), CD25, and ICOS (Figure 2A). Cutaneous 
mTregs also expressed higher levels of Foxp3 when compared with 
mTregs in peripheral blood (Supplemental Figure 2). With respect 
to memory markers, mTregs in the skin expressed high levels of 
CD27 and BCL-2 (Figure 2A). Interestingly, mTregs in human skin 
did not express high levels of IL-7Rα (CD127). This is in contrast to 
mTregs in murine skin, which have increased expression of CD127 
(relative to Tregs in skin-draining lymph nodes) and require IL-7 
for their maintenance in skin in the absence of antigen (4).
Approximately 24 hours after initiation of TCR stimulation in 
vitro, human CD4+ T cells begin to show increased Ki67 expression 
(10). In the presence of persistent TCR stimulation, the percentage 
of Ki67-expressing cells peaks at 72 hours and steadily declines to 
approximate baseline levels 5 days later. In addition, the majority 
of naive human CD45RO– Tregs convert to CD45RO+ cells within 
4 days of TCR stimulation (11). If similar kinetics apply in vivo, 
expression of Ki67 and CD45RO can be used to approximate the 
window of time that a T cell has encountered antigen in humans. 
It follows that the majority of cells that express both Ki67 and 
CD45RO are likely to have seen antigen 5 days or less prior to har-
vesting the tissue, whereas the majority of cells that express only 
CD45RO (i.e., Ki67– cells) are likely to have seen antigen greater than 
5 days before harvest. Consistent with previous reports (11, 12), 
approximately 10%–20% of CD45RO+ Tregs in peripheral blood 
are actively cycling, as evidenced by intracellular Ki67 expression 
(Figure 2A). In contrast, a significantly lower percentage of mTregs 
in the skin are cycling. This suggests that in the steady state, a larger 
percentage of mTregs in peripheral blood have recently seen anti-
gen compared with mTregs in skin, despite the fact that cutaneous 
mTregs express higher levels of Treg activation markers.
Lack of cytokine expression and demethylation of genomic DNA 
in intron 1 of the FOXP3 gene (TSDR locus) strongly correlate with 
Figure 1
Foxp3 expression in human adult and fetal skin. (A) Expression of 
Foxp3 on CD3+ T cells in PBMCs (Blood) and skin isolated from healthy 
adults. Scatter plot is gated on CD3+CD4+ cells. (B and C) Expression 
of Foxp3 and CD45RO on CD3+CD4+ T cells in adult PBMCs and in 
adult skin as well as human fetal skin. Results are combined data from 
five or more independent experiments. P values were determined using 
a 2-tailed unpaired Student’s t test.
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Figure 2
Tregs in human skin have an activated effector memory phenotype. (A and B) Expression of activation markers, memory markers, and cytokines 
from viable CD3+CD4+CD45RO+ T cells in PBMCs and skin isolated from healthy adults. Skin used for cytokine analysis in B was harvested from 
face or scalp. Scatter plots in B represent the percentage of cytokine-producing cells within Foxp3+ and Foxp3– gates. All gates are based on 
isotype control staining or unstimulated controls (for cytokine production in B). EC, extracellular. (C) Percentage of demethylation of genomic DNA 
in intron 1 of the FOXP3 gene (TSDR locus) of mTregs and mTconvs in PBMCs and skin isolated from healthy adults. Each pie chart represents 
a sorted population purified from a different donor, and numeric values within pie charts represent the percentage of demethylation at the TSDR 
locus. Numeric values in parentheses below each chart represent the percentage of Foxp3-expressing cells within each purified cell population. 
Cell sorting strategy is shown in Supplemental Figure 4. Results in A and B are representative data from more than fifteen independent experi-
ments. Results in C are from three or more replicate experiments. P values were determined using a 2-tailed unpaired Student’s t test.
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the suppressive function of mTregs isolated from human blood (6). 
When compared with mTreg cells in peripheral blood, mTregs iso-
lated from skin expressed significantly less IL-2 and IL-17, with no 
difference in IFN-γ or IL-10 expression (Figure 2B). Consistent with a 
phenotype of stably differentiated Tregs, cutaneous mTregs are fully 
demethylated at the TSDR region of the FOXP3 gene (Figure 2C). 
Taken together, these results suggest that Tregs in normal adult 
skin are a highly activated, stable effector memory Treg population.
mTregs in human skin preferentially localize to hair follicles. In order 
to define the anatomic localization of mTregs, we performed 
Treg-specific immunofluorescence microscopy on normal human 
skin. Consistent with findings in mice (4, 13), we observed that 
Tregs in human skin preferentially local-
ized to hair follicles (HFs) (Figure 3, A–C). 
We observed very few CD4+Foxp3+ cells 
in the interfollicular dermis, as most cells 
were localized in close proximity to the 
follicular epithelium. In contrast, CD4+ 
Foxp3– conventional T cells (Tconvs) dis-
played a more diverse distribution with 
little predilection for HFs. Consistent 
with these findings, flow cytometric quan-
tification showed that skin with high hair 
density (i.e., scalp and face) had signifi-
cantly higher percentages of Tregs when 
compared with skin with low hair den-
sity (Figure 3D). We found no significant 
difference in Treg percentages when data 
were stratified by gender and age (data not 
shown); however, only adult skin (>19 years 
of age) was available for analysis.
mTregs in human skin express unique TCRs. 
Discovering the nature of the antigens 
that T cells recognize in tissues is of fun-
damental importance in elucidating the 
biology of these cells. This is especially true for human tissue, in 
which antigen-specific T cell–directed therapies are being imple-
mented to treat autoimmune diseases and cancer (14). An essen-
tial question that remains to be answered is whether Tconvs and 
Tregs found in the same tissue recognize the same or different 
antigens. To begin to answer this question, we performed deep 
sequencing of the TCR β chain (TCRβ) from mTregs and mem-
ory CD4+ Tconvs (mTconvs) purified from normal human skin. 
TCR sequence diversity in the CDR3 region is an indirect measure 
of TCR specificity (15, 16). Thus, we compared TCRβ sequences 
between mTconvs and mTregs, with the rationale that sequences 
shared between these two cell populations suggest the possibility 
that they recognize the same antigens, whereas nonoverlapping 
sequences suggest that they recognize different antigens. We chose 
sequencing of TCRβ, because this chain of the TCR contains the 
most sequence diversity (15). Surprisingly, we found that very few 
TCRβ sequences were shared between mTconvs and mTregs (Fig-
ure 4 and Table 1), suggesting that these two T cell populations 
predominantly recognize different antigens. Although sequencing 
depth was limited by the number of cells we could extract from 
skin for these analyses, we used a series of Monte Carlo statistical 
simulations (see Methods) in four separate experimental replicates 
to determine that the mTreg population is qualitatively different 
from the mTconv population. Taken together, these results indi-
Figure 3
mTregs localize to HFs in human skin. (A–C) Confocal microscopy of 
normal human skin. Sections were stained for CD3 (green), Foxp3 
(red), CD1a (blue), and DAPI (gray). Scale bars: 100 μm. HFs auto-
fluoresce in blue. Arrows denote CD3+Foxp3+ cells (yellow). (D) Quan-
tification of Foxp3+ cells (within the CD3+ gate) in human adult skin by 
flow cytometry. Low hair density represents skin harvested from ana-
tomical sites with relatively lower HF density (trunk and upper proximal 
extremities), whereas high hair density represents skin harvested from 
anatomical locations with relatively higher hair density (scalp and face). 
Results are representative of more than five replicate experiments. 
P values were determined using a 2-tailed unpaired Student’s t test.
Figure 4
TCRβ sequencing of mTregs and memory Tconvs in human skin. (A) Gating strategy for sorting 
of mTconvs and mTregs from human skin harvested from healthy adults. Cells are pregated on 
viable CD3+CD4+ cells. (B) Hive plots showing relative abundance of unique TCRβ sequence 
clones and relative overlap of unique sequences between the Foxp3+ and Foxp3– pools. Each 
line represents one unique clone. The width of the lines denotes the relative abundance of each 
clone in the Foxp3+ and Foxp3– fractions or the pool of both populations. The most abundant 
clones (i.e., the widest lines) are positioned distally from the center of the hive, whereas the least 
abundant clones (thinnest lines) are located centrally. Lines that connect the Foxp3+ and Foxp3– 
fractions represent unique sequences shared between these cell populations. For example, in 
skin sample 2, the most abundant sequence in the Foxp3– fraction is present in relatively low 
frequency in the Foxp3+ fraction and represents the most abundant sequence in the entire pool. 
In this sample, this sequence is the only one shared between the Foxp3– and Foxp3+ cell pop-
ulations. P values were determined using Monte Carlo simulation for the probability that Foxp3+ 
cells were not a random sampling of the pooled population (see Methods).
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cate that mTregs in the skin possess a distinct TCR repertoire, 
suggesting that they recognize different antigens than those rec-
ognized by cutaneous mTconvs.
mTregs in human skin are nonmigratory. Based on chemokine recep-
tor expression patterns, it has been postulated that the majority of 
T cells in human skin are resident in this tissue and are thus non-
migratory (9). To a large extent, this conclusion is based on the lack 
of CCR7 expression seen on T cells isolated from skin. Given that 
CCR7 mediates the migration of memory T cells to secondary lym-
phoid organs (17), we analyzed the expression of this chemokine 
receptor on cutaneous mTregs and mTconvs. Consistent with 
previous reports (9), the majority of T cells isolated from human 
skin lacked CCR7 expression (Figure 5A). However, we observed 
a marked dichotomy within the small fraction of T cells that did 
express CCR7. This chemokine receptor was almost exclusively 
expressed on mTconvs (Figure 5A). These results suggested that 
mTregs are a more skin-resident (i.e., nonmigratory) cell popula-
tion when compared with mTconvs. To test this, we used an in vivo 
model of human T cell migration. When human skin is grafted 
onto immunodeficient mice, a functional human microcircula-
tion develops, allowing for the migration of human and murine 
cells to and from the grafted tissue (18). To determine the relative 
migratory potential of cutaneous mTregs and mTconvs in vivo, 
we grafted normal human skin onto immunodeficient NSG mice 
and assayed for these cell populations in the blood and spleen 3 
and 7 weeks after grafting. We performed the analyses 3 or more 
weeks after grafting to allow inflammation and wound healing 
to resolve and to allow human dermal microvessels to anasto-
mose with murine blood vessels (18). Consistent with the relative 
differences in CCR7 expression, we readily detected mTconvs in 
blood and spleen at all time points analyzed, whereas mTregs were 
undetectable in the blood and spleen and were found only in skin 
grafts (Figure 5B). Interestingly, we found that mTconvs prolifer-
ated in grafted skin, as evidenced by intracellular Ki67 expression; 
in contrast, mTregs maintained the basal prolifera-
tion levels (~5% Ki67-expressing cells) we observed in 
nongrafted normal skin (Figure 2A). Taken together, 
these results suggest that mTregs in human skin are 
nonmigratory and relatively anergic when compared 
with cutaneous mTconvs.
mTregs proliferate and produce IL-17 in psoriatic skin. 
The studies outlined above phenotypically and func-
tionally characterize mTregs in normal human skin. 
Because it is important to know how these cells func-
tion in both homeostatic and inflammatory contexts, 
we set out to functionally define these cells in the 
skin of patients with psoriasis. Due to inherent dif-
ficulties in obtaining adequate numbers of cells for 
functional analyses (from relatively small skin biopsy specimens), 
previous studies examining Tregs in psoriasis patients have relied 
on analyzing peripheral blood and/or performing semiquantita-
tive microscopic analyses on tissue sections (19, 20). It has become 
increasingly clear from both mouse models and studies of human 
disease that the secondary lymphoid organs and peripheral blood 
may not accurately represent the pathologic processes in tissues. 
We optimized our skin digestion protocol to functionally char-
acterize mTregs from 4-mm skin punch biopsies obtained from 
patients with clinically active psoriasis. In the majority of these 
studies, we compared lesional skin with nonlesional skin (defined 
as >10 cm away from a psoriatic plaque harvested from the same 
anatomical site) obtained from the same patient in an attempt to 
Table 1
TCRβ sequencing of mTregs and mTconvs in normal human skin
Skin  Unique Foxp3+  Unique Foxp3–  Shared sequences  P  
sample clones clones Foxp3+/– value
1 447 317 5 P < 0.0001
2 1,508 8,717 1 P < 0.0001
3 773 4,342 9 P < 0.0001
4 466 1,832 46 P < 0.0001
Quantification of unique TCRβ sequence clones after deep sequencing of genomic DNA 
from mTregs and mTconvs purified as described. Data shown are results from skin sam-
ples obtained from four different healthy donors.
Figure 5
mTregs in human skin are nonmigratory. (A) CCR7 expression on 
mTregs and mTconvs in human skin harvested from healthy adults. 
Cells were pregated on viable CD3+CD4+CD45RO+ cells. (B) Human 
skin was grafted onto immunodeficient NSG mice, and at specific times 
thereafter, grafted skin, blood, and spleen (not shown) were harvested 
and human T cells analyzed by flow cytometry. Cells were pregated on 
viable CD3+CD4+hCD45+ cells. (C) Absolute numbers of CD3+CD4+ 
hCD45+Foxp3+ and CD3+CD4+hCD45+Foxp3– cells in grafted skin and 
blood 3 and 7 weeks after grafting. Results are pooled data from two 
of five representative experiments with two or more mice per group. 
P values were determined using a 2-tailed unpaired Student’s t test.
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Figure 6
Functional analysis of cutaneous mTregs in patients with psoriasis. (A) Percentage and absolute number of T cells and Tregs in nonlesional 
psoriatic (NL-PSO) and lesional psoriatic (L-PSO) skin from patients (middle and right panels gated on CD4+ and CD3+ cells, respectively). 
(B) Percentage of mTregs and mTconvs in L-PSO skin or normal healthy adult skin (Control), pregated on viable CD3+ cells. (C) Intracellular IL-17 
production from mTregs and mTconvs in NL-PSO and L-PSO skin, gated on viable CD3+CD4+CD45RO+ cells. Middle panel is a representative 
flow cytometric plot of IL-17 production, and the scatter plot shows percentages of IL-17–producing cells within the Foxp3 gate. (D) Expression 
of Ki67 in mTregs and mTconvs in L-PSO skin or site-matched control skin, gated on viable CD3+CD4+CD45RO+ cells. (E) Expression of Ki67 
in mTregs and mTconvs in L-PSO or control skin, gated on viable CD3+CD4+CD45RO+ cells. Lines represent paired data from a single patient. 
Mean deltas between Foxp3– and Foxp3+ cells when comparing PSO versus control skin are 8.340 ± 5.05 versus 0.735 ± 0.50, respectively 
(P = 0.132). (F) MFI of Foxp3 and CD25 expression on Ki67+ and Ki67– mTregs in L-PSO skin, gated on viable CD3+CD4+CD45RO+Foxp3+ cells. 
(G) Foxp3 and CD127 expression on mTregs and mTconvs in L-PSO or site-matched control skin, gated on viable CD3+CD4+CD45RO+cells. 
Results are combined data from five or more replicate experiments.
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internally control for variability between patients and between 
anatomic locations. However, in situations where this was not 
possible, we compared cells obtained from psoriatic skin with site-
matched skin from normal healthy controls. As expected, when 
compared with nonlesional skin, psoriatic skin had an increased 
percentage of T cells (Figure 6A). We found that increased per-
centages and absolute numbers of Foxp3-expressing T cells were 
present in psoriatic skin (Figure 6A). The percentage of Foxp3+ 
cells that coexpressed CD45RO was similar between lesional and 
nonlesional skin (Figure 6B), suggesting that the increased Foxp3-
expressing cells we observed in lesional skin were not secondary 
to an influx of naive cells. When compared with nonlesional 
skin, CD45RO+CD4+Foxp3+ cells in lesional skin produced more 
IL-17 (Figure 6C). We have observed that the frequency of IL-17–
producing T cells in normal skin varies with anatomic location. 
Normal facial/scalp skin contains a higher percentage of IL-17–
producing T cells when compared with normal trunk skin (Sup-
plemental Figure 3). Interestingly, lesional skin harvested from 
the trunk of psoriasis patients contained a higher percentage of 
IL-17–producing mTregs when compared with either nonlesional 
trunk skin (harvested from the same patient) or facial/scalp skin 
harvested from normal healthy controls (Supplemental Figure 3). 
There was also a trend toward increased IFN-γ production from 
CD45RO+CD4+Foxp3+ cells isolated from lesional psoriatic skin 
compared with that seen in nonlesional skin; however, this was not 
statistically significant (Supplemental Figure 4). Interestingly, in 
contrast to both nonlesional skin and normal skin grafted onto 
immunodeficient mice (described above), CD45RO+CD4+Foxp3+ 
cells in psoriasis lesions were actively proliferating, with approxi-
mately 15% to 35% of cells expressing Ki67 compared with baseline 
levels of 5% in the skin of healthy controls (Figure 6D). A higher 
percentage of Foxp3+ cells were cycling compared with Foxp3– cells 
in 4 of 5 patients (Figure 6E). It is known that Foxp3 is transiently 
expressed in recently activated human CD4+ Tconvs (21, 22). Thus, 
it is possible that increased Foxp3-expressing cells in psoriatic skin 
represent a recently activated, proliferating Tconv population. 
However, human Tconvs that transiently express Foxp3 express 
this protein at lower levels compared with activated Tregs (23). In 
addition, Foxp3-expressing Tconvs express lower levels of CD25 
and do not repress CD127 expression or IL-2 production (23). In 
psoriatic skin, CD45RO+CD4+Foxp3+ cells have a phenotype that 
is completely different from that of Foxp3-expressing Tconvs. Pro-
liferating Foxp3+ cells in psoriatic skin express high levels of Foxp3 
and CD25 (Figure 6F), maintain low levels of CD127 expression 
(Figure 6G), and do not produce IL-2 (Supplemental Figure 4). 
Thus, our data suggest that Foxp3+ cells proliferating in psori-
atic skin are bona fide mTregs and are not transiently activated 
Tconvs. These results raise the intriguing possibility that excessive 
proliferation, perhaps associated with some production of effector 
cytokines, is a property of mTregs in inflammatory diseases such 
as psoriasis. Whether these putative Treg abnormalities are the 
cause or the consequence of inflammation is, of course, a question 
of fundamental importance for understanding the role of these 
cells in the disease process.
Discussion
In the studies described herein, we phenotypically and function-
ally characterize Tregs in human skin. We define this population 
as being bona fide effector memory cells with distinct cell surface 
marker expression, cytokine production, in situ localization, TCR 
expression, and functional capacity in two different biological con-
texts. Because of these attributes, we propose that this subset of 
Tregs is a unique cell population resident in human skin.
Our data are in agreement with previous reports showing that 
Tregs comprise approximately 10% of all T cells in normal human 
skin (8). We define this population as being highly activated mem-
ory cells similar to the “activated Treg” or “aTreg” population pre-
viously described in human blood (6). However, compared with 
aTregs in blood, we observed that mTregs in skin expressed higher 
levels of Treg activation markers, contained a lower percentage of 
cycling cells, and produced less IL-2 and IL-17 (Figure 2). These 
findings suggest that mTregs may be further along the Treg differ-
entiation pathway than aTregs and perhaps represent the final stage 
in Treg differentiation, a stage present only in peripheral tissues.
Sakaguchi and colleagues’ characterization of Tregs in human 
blood and our studies in transgenic mice support a model in 
which the life cycle of a Treg involves activation of naive cells by 
antigen, followed by proliferation and differentiation to become 
more potent suppressor cells (5, 6). We have previously shown that 
murine Tregs activated by self-antigen expressed in skin progres-
sively accumulate in this tissue (5). Here, we show that human 
fetal skin has significantly less Tregs than adult skin, with fewer 
CD45RO-expressing cells (Figure 1). This directly supports a model 
in which throughout the life of an individual, Tregs are continually 
exposed to cutaneous antigens and progressively accumulate in 
skin. The nature of the antigens recognized by mTregs (i.e., self-pro-
teins expressed in the postnatal environment, foreign pathogens, 
and/or commensal microbes) remains to be determined.
It is intriguing that in both mice and humans, mTregs preferen-
tially localize to the epithelium of HFs (Figure 3 and refs. 4, 13). This 
may be a consequence of the antigens that mTregs recognize and/or 
a unique niche provided by these highly specialized and dynamic 
organelles. HFs are constantly cycling, with waves of new protein 
expression at each stage of the cycle that change over time (24). In 
addition, HFs are colonized by a multitude of microbes (25). Thus, 
it is likely that many HF-associated antigens are not expressed in 
the thymus, making peripheral tolerance mechanisms essential to 
prevent autoimmune attack. In addition, epidermal stem cells reside 
in a specific HF niche, providing another important reason to pre-
vent autoimmunity directed at these structures (26). It is possible 
that HFs recruit the services of Tregs for this purpose. Consistent 
with the idea that Tregs play an important role in regulating HF- 
associated autoimmunity are recent studies of alopecia areata (AA). 
AA is one of the most common autoimmune diseases in humans 
and results from a T cell–mediated autoimmune attack on HFs (27). 
Interestingly, the largest genome-wide association study in patients 
with AA shows a strong correlation with polymorphisms in CTLA4, 
CD25, and EOS (28), all of which play essential roles in Treg function 
(29, 30). A subsequent study directly correlates polymorphisms in 
the FOXP3 promoter with AA (31).
Our comparison of TCRβ sequences between mTconvs and 
mTregs in the skin shows very little overlap, suggesting that these 
two populations recognize different antigens (Figure 4 and Table 1). 
Previous studies examining TCR repertoires between Tconvs 
and Tregs in human blood and murine lymphoid organs have 
revealed various degrees of overlap (32–35). However, few studies 
have examined these T cell populations in tissues. Perhaps the 
best-characterized tissue-specific Tregs to date are those that reside 
in VAT (3, 36). Consistent with our data, TCR repertoires between 
Tregs and Tconvs in murine VAT show very little overlap (36). 
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Thus, it seems that tissues are enriched for T cells that have a 
narrow TCR repertoire when compared with blood and second-
ary lymphoid organs and that TCR specificities in tissues differ 
between Tregs and other CD4+ T cell populations. It is intriguing 
to speculate that in normal healthy tissue, Tregs recognize self-an-
tigens and/or commensal microbes, whereas Tconvs recognize 
foreign pathogens. To the best of our knowledge, this is the first 
report of TCR sequencing of cells purified from peripheral tissue 
in humans. Determining the antigens that Tregs and Tconvs rec-
ognize in tissues may have a profound impact on our ability to spe-
cifically manipulate these cell populations for therapeutic benefit.
Examination of mTregs in human skin grafted onto immunode-
ficient mice revealed this population to be nonmigratory and rel-
atively anergic compared with cutaneous Tconvs (Figure 5). This 
is consistent with recent studies performed in murine skin, where 
Tregs were relatively nonmigratory in the steady state when com-
pared with other T cell populations in skin (13). In our humanized 
mouse model, it is unknown whether Tconvs cycle in response to 
lymphopenia or to recognition of xenoantigen and whether entry 
into the cell cycle contributes to their migratory potential. Fur-
thermore, although differences in CCR7 expression could predict 
differences in migratory capacity, the extent to which this chemok-
ine receptor mediates Tconv migration out of grafted skin in this 
model is not known. Nevertheless, grafting human skin onto 
immunodeficient mice represents one of the best in vivo models 
for studying human cutaneous T cell migration. Our assay clearly 
reveals mTregs to have markedly less migratory potential com-
pared with that of Tconvs. It is intriguing to speculate that mTregs 
in skin have evolved to become tissue-resident cells as a result of a 
variety of essential functions they play within the tissue, making 
their continued presence essential for their tissue-specific func-
tion. Indeed, VAT Tregs in mice (and not VAT Tconvs) have been 
shown to play a role in both glucose and lipid metabolism that 
may be independent of their ability to suppress inflammation (3).
Although mTregs minimally proliferate in normal skin, we found 
that these cells actively cycle in inflamed lesions of psoriasis (Figure 6). 
Despite increasing in percentage relative to Tconvs, mTregs are 
unable to resolve disease. Thus, we observed that mTregs in psori-
atic skin appear to be qualitatively defective in controlling inflam-
mation. This is supported by previous work showing that local 
production of IL-6 impairs Treg function in patients with psoriasis 
(20). In this study, DCs, ECs, and T cells in psoriatic skin expressed 
high levels of IL-6, and Tregs in lesional skin expressed IL-6R. 
Peripheral blood–derived DCs from psoriatic patients inhibited 
Treg-mediated suppression in vitro in an IL-6–dependent fashion, 
with no effect on Treg proliferation. The inability of mTregs to 
resolve disease may also in part be a result of aberrant IL-17 pro-
duction by this cell population. A small but significantly increased 
percentage of mTregs in psoriatic skin produced IL-17 compared 
with mTregs in nonlesional skin (Figure 6C), and expression of 
this cytokine was normally suppressed in mTregs when compared 
with aTregs in peripheral blood (Figure 2B). Consistent with this, 
a recent report showed that peripheral blood–derived Tregs from 
patients with psoriasis more readily differentiate into IL-17A–pro-
ducing cells upon stimulation ex vivo (19).
The magnitude and nature of Treg defects in autoimmune dis-
eases remain fundamental and largely unresolved issues. In order 
to address this, it is essential to first define the properties of these 
cells in healthy individuals. Because of the emerging idea that 
immune regulation occurs largely in tissues, we chose to address 
these questions in an accessible human tissue, the skin. The stud-
ies described herein are initial experiments attempting to define 
long-lived Tregs in healthy human skin. Our preliminary studies 
of psoriasis patients have already raised the possibility of unex-
pected Treg defects associated with this disease. Further elucidat-
ing the fundamental biology of Tregs in tissues and the factors 
that influence their maintenance and functions in health and dis-
ease is an essential next step in our attempt to understand how 
immune responses are regulated in humans.
Methods
Human specimens. Normal human skin was obtained from patients at 
UCSF undergoing elective surgery, in which healthy skin was discarded 
as a routine procedure. Skin was obtained from psoriasis patients (female 
and male; age range 20–76 years) who had been off all systemic therapy for 
greater than 3 weeks prior to surgery. All patients had greater than 10% 
body surface area involvement, with psoriasis severity index scores (PASI) 
ranging from 10 to 40. Four-millimeter punch biopsies were obtained from 
psoriatic plaques (lesional) and from clinically normal-appearing skin 
(nonlesional) at least 10 cm away from the lesional skin biopsies (i.e., in 
the same anatomic location).
Mice. All animal studies were performed in compliance with the US 
Department of Health and Human Services guidelines for the care and 
use of laboratory animals and were approved by the Laboratory Animal 
Resource Center of UCSF. NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice were 
obtained from The Jackson Laboratory.
Skin digestion and flow cytometry. Skin samples were stored at 4°C in a 
sterile container with PBS and gauze until the time of digestion. Sub-
cutaneous fat and hair were removed, and skin was minced finely with 
dissection scissors and mixed in a 6-well plate with 3 ml of digestion 
buffer consisting of 0.8 mg/ml Collagenase Type 4 (4188; Worthington), 
0.02 mg/ml DNAse (DN25-1G; Sigma-Aldrich), 10% FBS, 1% HEPES, and 
1% penicillin/streptavidin in RPMI medium. Samples were incubated over-
night in 5% CO2 and harvested with wash buffer (2% FBS, 1% penicillin/
streptavidin in RPMI medium), then double filtered through a 100-μm 
filter, centrifuged, and counted. Human PBMCs were prepared by Ficoll-
Hypaque gradient centrifugation. Fresh, thawed PBMCs were incubated 
overnight with digestion buffer, similarly to the skin samples. For detec-
tion of intracellular cytokine production, skin cells and PBMCs were stim-
ulated with 70 ng/ml PMA and 700 ng/ml ionomycin in the presence of 
brefeldin A (Sigma-Aldrich) for 4 to 5 hours. The following antibodies 
were used for flow cytometry: anti–hBCL-2-PE (BD Biosciences); anti–
hCCR7-PE (BioLegend); anti–hCD3 (-Alexa700, -APC, -APC-eFluor780, 
-eFluor605, -FITC, or -PE from eBioscience or -PE-Cy7 from BioLegend); 
anti–hCD4 (-PE-Cy7 from BD or -PerCP from BioLegend); anti–hCD25-
PE-Cy7 (BD); anti–hCD27-APC-eFluor780 (eBioscience); anti–hCD45RO-
FITC (eBioscience); anti–hCD127-Brilliant Violet 650 (BioLegend); 
anti–hCTLA-4-PE (eBioscience); anti–hFoxp3 (-eFluor 450 or -APC 
from eBioscience); anti-hICOS-APC (eBioscience); anti–hIFN-γ (-APC 
from eBioscience or -Alexa700 from BioLegend); anti–hIL-2-Alexa700 
(BioLegend); anti–hIL-10-APC (BD); anti–hIL17A -PE (eBioscience); anti–
Ki67 (-Alexa647 or -PE-Cy7 from BD); anti–hTNF-α-PE-Cy7 (eBiosci-
ence); and LIVE/DEAD Fixable Aqua Dead Cell Stain (Life Technologies). 
Data were acquired by an LSRFortessa flow cytometer (BD Biosciences) 
and analyzed using FlowJo software (Tree Star Inc.).
FOXP3 gene DNA methylation. Multiplex quantitative PCR was used to 
analyze the methylation status of specific CpG dinucleotides in the TSDR 
region of the human FOXP3 gene as described previously (37). PCR primers 
and probes used in these assays were: GGTTTGTATTTGGGTTTTGTTGT-
TATAGT (forward); CTATAAAATAAAATATCTACCCTCTTCTCTTCCT 
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random subsamplings, we calculated the Bhattacharyya coefficient (BC) 
for each subsample and pool pair, which quantifies the similarity between 
each subsample and the pool pair and is calculated as: 
     (Equation 1)
where fj,1 and fj,2 are the frequencies of clonotype j in samples 1 and 2, 
respectively, and n is the number of unique clonotypes present across sam-
ples 1 and 2. The distribution of BC scores in the Monte Carlo simulation 
were then used to calculate a P value for the probability that the FoxP3+ 
cells were not a random sampling of the full skin TCRβ cell population.
Skin grafting. Normal human skin (~1 cm × 1 cm) was grafted onto the 
backs of NSG mice as previously described (38). Briefly, healthy skin 
was dermatomed to a thickness of 0.4 mm and transplanted using an 
absorbable tissue seal (Vetbond; 3M). Bandages were maintained for 
1 week after grafting. Transplanted human skin, peripheral blood, and 
spleens were harvested, processed, and analyzed by flow cytometry 3 and 
7 weeks after grafting.
Statistics. Analysis of the TCR sequencing data is described above. 
Other group-versus-group data comparisons were performed using a 
2-tailed unpaired Student’s t test. P values of less than 0.05 were con-
sidered significant.
Study approval. Studies using human tissue were approved by the UCSF 
Committee on Human Research (study number 10-02830) and by the IRB 
of UCSF. All patients provided written informed consent prior to biopsies. 
Fetal skin samples were obtained from the UCSF Medical Center and San 
Francisco General Hospital (San Francisco, California, USA). Samples were 
from second trimester skin that would have otherwise been discarded at 
the time of the procedure. Blood samples were obtained from healthy adult 
volunteers (study number 12-09489). Animal experiments were approved 
by the IACUC of the UCSF.
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(reverse); VIC-TGGTGGTTGGATGTGTTG-MGBNFQ (unmethylated 
probe); and 6FAM-CGGTCGGATGCGTC-MGBNFQ (methylated probe). 
The sorting strategy for mTreg and mTconv purification is outlined in Sup-
plemental Figure 5. Briefly, viable CD3+CD4+CD45RO+CD25hiCD27hi cells 
and CD3+CD4+CD45RO+CD25–CD27– cells were FACS purified from dis-
carded skin harvested from normal healthy males. In addition, viable CD3+ 
CD4+CD45RO+CD25hiCD27hi cells, CD3+CD4+CD45RO–CD25hiCD27hi 
cells, and CD3+CD4+CD45RO+CD25–CD27– cells were purified from 
healthy male human PBMC samples. Foxp3 staining on sorted cell popu-
lations verified that CD25hiCD27hi cells were greater than or equal to 75% 
Foxp3+ and that CD25–CD27– cells were less than or equal to 8.3% Foxp3+.
Immunofluorescence microscopy. Skin specimens were immediately placed 
in Tissue-Tek OCT Compound (Fisher Scientific), frozen on dry ice, and 
stored at –80°C. Cryosections (6-mm) were fixed in 100% acetone and 
stained for Foxp3 (rat IgG2a, clone PCH101, dilution 1:50; eBioscience), 
CD3 (rabbit IgG, polyclonal, dilution 1:500; Abcam), and CD1a (mouse 
IgG1, clone 7A7, dilution 1:100; Abcam). Secondary antibodies recogniz-
ing rat (donkey IgG, Alexa Fluor 488), rabbit (donkey, Alexa Fluor 555) and 
mouse (goat, Alexa Fluor 647) were used at 1:1,000 and obtained from Life 
Technologies, as was the DAPI used for nuclear staining. Confocal images 
were acquired using a Nikon C1si spectral confocal microscope.
TCR sequencing. Genomic DNA was isolated from FACS-purified CD3+ 
CD4+CD45RO+Foxp3+ and CD3+CD4+CD45RO+Foxp3– subsets. TCRβ 
repertoire sequencing was performed using GigaMune Rep-Seq molec-
ular kits and ClonoByte repertoire analysis software (GigaGen). Briefly, 
genomic DNA was amplified by PCR with a set of 45 primers targeting 
the TCRβ V genes paired with 13 primers targeting the TCRβ J genes. 
This set of 58 primers amplifies the CDR3 region of TCRβ and also intro-
duces universal priming sites to the amplicons. A second round of PCR 
was performed on the resulting amplicons using universal primers. Each 
sample was indexed with a unique 6-nucleotide tag, allowing demulti-
plexing of samples after sequencing. Samples were then sequenced on a 
MiSeq sequencer (Illumina) to a length of 150 bp. The sequencing reads 
for each sample were analyzed using ClonoByte TCRβ repertoire analysis 
software (GigaGen). ClonoByte aligns each sequence to the set of TCRβ V 
and TCRβ J genes and identifies the conserved cysteine and phenylalanine 
that form the boundaries of the CDR3. For quality purposes, reads that 
did not have a uniquely identifiable V gene, were out of frame, as defined 
by the conserved cysteine and phenylalanine, or contained a stop codon 
or a sequencing error in the form of an uncalled base, were discarded. All 
other nucleotide sequences were translated into their amino acid equiva-
lent. To avoid distorting the diversity of the TCRβ CDR3 repertoire by the 
tail of low-abundance clones caused by PCR and sequencing errors, we ran 
a no-template negative control (NTC) alongside each batch of samples for 
every stage in the process, including sequencing. In the rare cases in which 
the NTC showed a strong spurious CDR3 signal, we removed those clones 
from all corresponding samples. Additionally, we removed all reads map-
ping to clones whose frequency was less than 0.1% of the most abundant 
clone’s frequency and then normalized the remaining frequencies to the 
total number of remaining reads. This conservative criterion minimizes 
the chance of unique clones likely to have arisen due to PCR and sequenc-
ing errors being treated as real. A Monte Carlo simulation was conducted 
for each skin sample, wherein a simulated pool of Foxp3+ and Foxp3– cells 
was created, followed by a random subsampling of clones equal to the 
number of clones in the Foxp3 population for that sample. After 10,000 
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